Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer.

Ni, Boxiong; Kong, Xianglong; Yan, Yubo; Fu, Bicheng; Zhou, Fucheng; Xu, Shidong

Ni, Boxiong; Kong, Xianglong; Yan, Yubo; Fu, Bicheng; Zhou, Fucheng; Xu, Shidong.

Afiliación

Ni B; Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.
Kong X; Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.
Yan Y; Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.
Fu B; Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhou F; Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.
Xu S; Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.

Front Cell Infect Microbiol ; 13: 1091825, 2023.

Article en En | MEDLINE | ID: mdl-36743312

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Microbioma Gastrointestinal; Neoplasias Pulmonares; Humanos; Carcinoma de Pulmón de Células no Pequeñas/patología; Biomarcadores; Metabolómica/métodos; Esfingolípidos

Palabras clave

IPA; biomarkers; early-stage NSCLC; gut microbiome; serum metabolite

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Microbioma Gastrointestinal / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Cell Infect Microbiol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google